Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03382886
Title Nivolumab and Bevacizumab in Patients With Advanced and or Metastatic Hepatocellular Carcinoma (NUANCE)
Acronym NUANCE
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors University of Utah
Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.